International Biotechnology Trust’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-96,419
Closed -$387K 61
2016
Q4
$387K Buy
+96,419
New +$387K 0.17% 48